Farahnak Assadi to Male
This is a "connection" page, showing publications Farahnak Assadi has written about Male.
Connection Strength
0.775
-
Electrocardiography is Unreliable to Detect Potential Lethal Hyperkalemia in Patients with Non-dialysis Chronic Kidney Disease. Pediatr Cardiol. 2022 Jun; 43(5):1064-1070.
Score: 0.065
-
Long-term cardiometabolic consequences among adolescent offspring born to women with type1 diabetes. Prim Care Diabetes. 2022 02; 16(1):122-126.
Score: 0.063
-
Differentiating syndrome of inappropriate ADH, reset osmostat, cerebral/renal salt wasting using fractional urate excretion. J Pediatr Endocrinol Metab. 2021 Jan 27; 34(1):137-140.
Score: 0.059
-
Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction. J Pediatr Urol. 2020 Feb; 16(1):107.e1-107.e5.
Score: 0.055
-
Urine KIM-1 as a Potential Biomarker of Acute Renal Injury After Circulatory Collapse in Children. Pediatr Emerg Care. 2019 Feb; 35(2):104-107.
Score: 0.052
-
Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease. Pediatr Nephrol. 2018 08; 33(8):1405-1409.
Score: 0.049
-
Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus. Am J Nephrol. 2015; 42(1):65-9.
Score: 0.039
-
Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol. 2014 Feb; 27(1):51-6.
Score: 0.036
-
Hyponatremia: a problem-solving approach to clinical cases. J Nephrol. 2012 Jul-Aug; 25(4):473-80.
Score: 0.033
-
Simplified diagnostic algorithm for evaluation of neonates with prenatally detected hydronephrosis. Iran J Kidney Dis. 2012 Jul; 6(4):284-90.
Score: 0.033
-
Childhood Henoch-Schonlein nephritis: a multivariate analysis of clinical features and renal morphology at disease onset. Iran J Kidney Dis. 2009 Jan; 3(1):17-21.
Score: 0.026
-
Vasoconstrictor-induced hypertension following multiple blood transfusions in children with congenital hemolytic anemia. Iran J Kidney Dis. 2008 Jul; 2(3):132-6.
Score: 0.025
-
Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol. 2008 May; 29(3):580-4.
Score: 0.024
-
C-reactive protein and incident left ventricular hypertrophy in essential hypertension. Pediatr Cardiol. 2007 Jul-Aug; 28(4):280-5.
Score: 0.023
-
Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol. 2007 Jan-Feb; 28(1):27-33.
Score: 0.023
-
Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug. Pediatr Cardiol. 2006 Mar-Apr; 27(2):238-42.
Score: 0.021
-
Leukonychia associated with increased blood strontium level. Clin Pediatr (Phila). 2005 Jul-Aug; 44(6):531-3.
Score: 0.020
-
Value of urinary excretion of microalbumin in predicting glomerular lesions in children with isolated microscopic hematuria. Pediatr Nephrol. 2005 Aug; 20(8):1131-5.
Score: 0.020
-
Autonomic dysreflexia manifested by severe hypertension. Med Sci Monit. 2004 Dec; 10(12):CS77-9.
Score: 0.019
-
Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene. Am J Kidney Dis. 2003 Jan; 41(1):E3.
Score: 0.017
-
Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol. 2002 Feb; 17(2):107-10.
Score: 0.016
-
Validity of anthropometric indices in predicting high blood pressure risk factors in Iranian children and adolescents: CASPIAN-V study. J Clin Hypertens (Greenwich). 2020 06; 22(6):1009-1017.
Score: 0.014
-
Performance of modified blood pressure-to-height ratio for diagnosis of hypertension in children: The CASPIAN-V study. J Clin Hypertens (Greenwich). 2020 05; 22(5):867-875.
Score: 0.014
-
Adjunctive acetazolamide therapy for the treatment of Bartter syndrome. Int Urol Nephrol. 2020 Jan; 52(1):121-128.
Score: 0.014
-
Impact of dyslipidemia on estimated glomerular filtration rate in apparently healthy children and adolescents: the CASPIAN-V study. World J Pediatr. 2019 Oct; 15(5):471-475.
Score: 0.013